Several potential health hazards are the reasons for the 2012 recall of Stryker hip replacements, according to Drugwatch. Stryker Corporation has terminated distribution of the Rejuvenate Modular, ABG II Modular-Neck Hip Stems and Accolade TMZF since that date.
The public recall notice points to fretting and corrosion, metallosis (metal poisoning), necrosis (tissue and bone death), metal allergic reaction and osteolysis (bone loss) as potential health hazards, according to Drugwatch. Stryker Corporation issued an urgent field safety notice three months before the recall. The company warned surgeons and hospitals about the risk of metal shards leaching into the patient’s body. Discovery of the health hazards came after patients complained of side effects soon after installation of the medical device. Revision surgery is required to treat these side effects. Stryker Corporation faces more than 1,700 lawsuits as of August 2014.